HIV-1 p24 Antibody (1941) is a mouse monoclonal IgG1 antibody that detects p24 protein of HIV-1 by western blotting (WB), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Anti-p24 antibody (1941) plays a crucial role in the study of HIV-1, as p24 is a key structural protein that forms the viral capsid, which is essential for the protection and delivery of the viral genome into host cells. The capsid′s integrity is vital for the virus′s ability to infect and replicate within the host, making p24 a significant target for both diagnostic and therapeutic strategies against HIV. Understanding the structure and function of p24 can aid in the development of vaccines and antiviral drugs, as well as in monitoring viral load in infected individuals. p24 monoclonal antibody (1941) in various applications helps researchers gain insights into the dynamics of HIV infection and the immune response, ultimately contributing to advancements in HIV research and treatment.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
HIV-1 p24 Antibody (1941) References:
- Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice. | Krupka, M., et al. 2015. Immunol Lett. 166: 36-44. PMID: 26021827
- Detection of HIV-1 p24 at Attomole Level by Ultrasensitive ELISA with Thio-NAD Cycling. | Nakatsuma, A., et al. 2015. PLoS One. 10: e0131319. PMID: 26098695
- Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24. | Tjiam, MC., et al. 2016. AIDS. 30: 2757-2765. PMID: 27603291
- Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents. | Passaes, CPB., et al. 2017. J Virol. 91: PMID: 28077644
- Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles. | Larijani, MS., et al. 2020. Curr Drug Deliv. 17: 387-395. PMID: 32183667
- HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c. | Larijani, MS., et al. 2021. Curr Drug Deliv. 18: 1014-1021. PMID: 33388019
- Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine. | Sadat Larijani, M., et al. 2021. Virus Res. 298: 198403. PMID: 33775753
- Surface Plasmon Resonance Assay for Label-Free and Selective Detection of HIV-1 p24 Protein. | Sarcina, L., et al. 2021. Biosensors (Basel). 11: PMID: 34204930
- Fluorescence and visual immunoassay of HIV-1 p24 antigen in clinical samples via multiple selective recognitions of CdTe QDs. | Tang, Z., et al. 2021. Mikrochim Acta. 188: 422. PMID: 34791532
- A click chemistry amplified nanopore assay for ultrasensitive quantification of HIV-1 p24 antigen in clinical samples. | Wei, X., et al. 2022. Nat Commun. 13: 6852. PMID: 36369146